期刊文献+

miR-181b调控靶基因TIMP-3对肝癌细胞侵袭迁移能力的影响 被引量:1

TIMP-3 regulated by miR-181b as a target gene on invasion and migration of hepatocellular carcinoma cells
原文传递
导出
摘要 目的 探讨miR-181b对靶基因的金属蛋白酶组织抑制因子-3(tissue inhibitor of met-allo proteinases 3,TIMP-3)的调控作用及其对肝癌细胞体外侵袭迁移能力的影响.方法 采用qRT-PCR检测肝细胞癌(HCC)组织和不同人HCC细胞系中miR-181b的表达.Western-blot检测TIMP-3在HCC中蛋白的表达.选择miR-181b高表达HCC细胞系SKHep-1,通过报告基因检测试验,观察miR-181b对TIMP-3的调控作用.分别通过Transwell小室和细胞划痕试验,观察阻断SKHep-1细胞miR-181b表达对其侵袭、迁移能力的影响.结果 miR-181b在HCC组织中mRNA的表达明显高于癌旁组织和正常肝组织(P<0.01),其高表达与HCC高侵袭转移密切相关(P<0.01).TIMP-3在HCC中蛋白表达明显低于癌旁组织和正常肝组织(P<0.05).miR 181b在人HCC细胞Hep3B、HepG2、Huh-7、SKHep-1、SNU182、SNU449和肝细胞中均有表达,其中在SKHep-1中表达最高(P<0.01).高表达miR-181b抑制带有TIMP-3' UTR的荧光素酶的表达(P<0.05),抑制miR-181b不仅能降低SK-hep1的HCC细胞迁移能力(P<0.05),还可降低其侵袭能力(P<0.01).结论 miR-181b可能通过下调TIMP-3基因表达促进HCC侵袭和迁移能力. Objective To explore the impact of TIMP 3 regulated by miR-181b as a target gene on invasion and migration of hepatocellular carcinoma (HCC) in vitro.Methods The expressions of miR-181b were detected using SYBR Green real-time fluorescence quantitative polymerase chain reaction on liver cancer specimens and on HCC cell lines.The protein expression of TIMP 3 in HCC was detected using westen blot,and SKHep-1 as a cell line expressing high miR-181b was chosen through reporter gene experiment.TIMP-3 as a target gene regulated by miR-181b and its effect on invasion and migration treated by anti-miR-181 b were studied using transwell and cell scarification test,respectively.Results The expression of miR-181b in HCC was higher than cancer-adjacent tissues and normal liver tissues.The differences among them were significant.There was a correlation between the high expression of miR-181b and invasiveness and metastasis in HCC.The protein expression of TIMP-3 in HCC was significantly lower than normal liver tissues and cancer-adjacent tissues.Expression of miR-181b mRNA was detected in various HCC cell lines such as Hep3B,HepG2,Huh 7,SKHep-1,SNU182,SNU449 and hepatocyte,with the expression of miR-181b in SKHep-1 being the highest (P〈0.01).TIMP3-3UTR was low when the expression of miR-181b was high (P〈0.05).The invasion and migration abilities of SKHep-1 were significantly inhibited by anti-miR-181b (P〈0.05).Conclusion The data suggested that miR-181b promoted invasion and migration of SKHep-1 by down-regulating TIMP-3 in HCC.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第1期29-32,共4页 Chinese Journal of Hepatobiliary Surgery
基金 广东省科技计划资助项目(20088030301016) 东莞市科技计划项目(DK0821)
关键词 肝肿瘤 基因表达调控 肿瘤 肿瘤转移 Liver neoplasms Gene expression regulation, neoplastic Neoplasm metastasis
  • 相关文献

参考文献9

  • 1王家祥,韦源,胡倩,刘秋亮,范应中,杨合英,李苏宁,张大,张谦.人肝癌细胞株与正常肝细胞株MicroRNA差异表达谱研究[J].中华肝胆外科杂志,2011,17(6):492-496. 被引量:2
  • 2Wang B, Hsu SH, Majumder S, et al. TGF-mediated upreg- ulation of hepatic miR-181h promotes heapatocarcinogenesis by targeting TIMP3[J]. Oncogene, 2010,29 : 1787 -1797.
  • 3Ji J, Yamashita T, Budhu A, et al. Identification of microR- NA-181 by genome wide screening as a critical player in Ep- CAM-positive hepatic cancer stem cells [J].Hepatology, 2009,50: 472-480.
  • 4Cruz Mufioz W, Kim I, Nhokha R, et al. TIMP 3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis[J]. Oncogene, 2006,25 : 650 -655.
  • 5Cruz-Munoz W, Sanchez OH, Di Grappa M, et al. Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp 3-/-mice[J]. Oncogene, 2006, 25: 6489 -6496.
  • 6吕国丽,文剑明,胥健敏,张萌,徐若冰,田保玲.人肝细胞癌金属蛋白酶组织抑制因子-3的表达及与其基因启动子甲基化的关系[J].中华病理学杂志,2003,32(3):230-233. 被引量:6
  • 7Czech MP. MicroRNAs as therapeutic targets[J]. N Engl J Med, 2006,354:1194-1195.
  • 8Kota J, Chivukula RR, (YDonnell KA, et al. Therapeutic mi- croRNA delivery suppresses tumorigenesis in a murine liver cancer model[J].Cell, 2009,137 : 1005-1017.
  • 9Tran PL, Vigneron JP, Pericat D, et al. Gene therapy for hepato- cellular carcinoma using non-viral vectors composed of his guanidin- ium-tren-cholesterol and plasmids encoding the tissue inhihitors of metalloproteinases TIMP-2 and TIMP [J]. Cancer Gene Ther, 2003,10:435-444.

二级参考文献4

共引文献6

同被引文献18

  • 1Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61 (2):69-90.
  • 2Mann CD,Neal CP,Garcea G,et al.Prognostic molecular markers in hepatocellular carcinoma:a systematic review[J].Eur J Cancer,2007,43(6):979-992.
  • 3Thiery JP,Acloque H,Huang RY,et al.Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139 (5):871-890.
  • 4Pan D.The hippo signaling pathway in development and cancer[J].Dev Cell,2010,19(4):491-505.
  • 5Xu MZ,Yao TJ,Lee NP,et al.Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma[J].Cancer,2009,115(19):4576-4585.
  • 6Chan SW,Lim C J,Guo K,et al.A role for TAZ in migration,invasion,and tumorigenesis of breast cancer cells[J].Cancer Res,2008,8 (8):2592-2598.
  • 7Yang J,Weinberg RA.Epithelial-mesenchymal transition:at the crossroads of development and tumor metastasis[J].Dev Cell,2008,14(6):818-829.
  • 8van Zijl F,Zulehner G,Petz M,et al.Epithelial-mesenchymal transition in hepatocellular carcinoma[J].Future Oncol,2009,5(8):1169-1179.
  • 9Matsumura T,Makino R,Mitamura K.Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas[J].Clin Cancer Res,2001,7 (3):594-599.
  • 10Derycke LD,Bracke ME.N-cadherin in the spotlight of cell-cell adhesion,differentiation,embryogenesis,invasion and signalling[J].Int J Dev Biol,2004,48(5-6):463-476.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部